ASKG-712

N/A

Report date: 2026/03/18 17:46:06

Base Information

Drug NameASKG-712
Drug Alias NameASKG-712AM-712VIS-101
ClassificationBiologics > Protein drugs > Recombinant protein > Fusion protein
Mechanisms of ActionVascular endothelial growth factor A inhibitorsAngiopoietin-2 inhibitors
TargetsVascular endothelial growth factor AAngiopoietin-2
Therapy Area/IndicationsDiabetic macular oedemaWet age-related macular degenerationGeographic Atrophy +[4] 
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryUnited StatesMainland China
CombinationsNo
Global Highest StatusPhase 2 Clinical
Highest Status in ChinaPhase 1 Clinical
Originator CompaniesAskgene Pharma
China Registration ClassClass 1 therapeutic biologic in China

Develop Information

Active CompaniesJiangsu Aosaikang Biomedical Co LtdYunding Xinyao Co LtdVisara Inc +[8] 
Inactive CompaniesN/A
Active IndicationsDiabetic macular oedemaWet age-related macular degenerationGeographic Atrophy +[4] 
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A